A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model

BACKGROUND: Although hepatitis B infection is the major cause of chronic liver disease in Iran, no studies have employed economic evaluations of the medications used to treat Iranian patients with chronic hepatitis B (CHB). Therefore, the cost-effectiveness of the different treatment options for thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshavarz, Khosro, Kebriaeezadeh, Abbas, Alavian, Seyed Moayed, Akbari Sari, Ali, Rezaei Hemami, Mohsen, Lotfi, Farhad, Hashemi Meshkini, Amir, Javanbakht, Mehdi, Keshvari, Maryam, Nikfar, Shekoufeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091008/
https://www.ncbi.nlm.nih.gov/pubmed/27822262
http://dx.doi.org/10.5812/hepatmon.37435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091008/
https://www.ncbi.nlm.nih.gov/pubmed/27822262
http://dx.doi.org/10.5812/hepatmon.37435

Ejemplares similares